Experimental Treatments of Endometriosis
This review summarizes novel experimental treatments for endometriosis, an estrogen-dependent disease, focusing on molecular targets to improve upon current therapies with significant side effects and limited efficacy for infertility.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (91)
- A matrix metalloproteinase inhibitor, ONO-4817, retards the development of mammary tumor and the progression of uterine adenomyosis in mice. via openalex
- Anastrazole and oral contraceptives: a novel treatment for endometriosis via openalex
- Angiostatic agents prevent the development of endometriosis-like lesions in the chicken chorioallantoic membrane via openalex
- Antiangiogenesis Therapy for Endometriosis via openalex
- Antiprogestin and/or gonadotropin-releasing hormone agonist for endometriosis treatment and bone maintenance: a 1-year primate study. via openalex
- An update on the pharmacological management of endometriosis via openalex
- Are aromatase inhibitors effective in endometriosis treatment? via openalex
- Aromatase inhibitors: the next generation of therapeutics for endometriosis? via openalex
- A selective estrogen receptor-β agonist causes lesion regression in an experimentally induced model of endometriosis via openalex
- Atorvastatin causes regression of endometriotic implants in a rat model via openalex
- Comparison of the effects of raloxifene and anastrozole on experimental endometriosis via openalex
- Dopamine agonist administration causes a reduction in endometrial implants through modulation of angiogenesis in experimentally induced endometriosis via openalex
- Effect of aromatase inhibitors on ectopic endometrial growth and peritoneal environment in a mouse model of endometriosis via openalex
- Effect of pentoxifylline on vascular endothelial growth factor C and flk-1 expression on endometrial implants in the rat endometriosis model via openalex
- Effect of Vascular Endothelial Growth Factor Inhibition on Endometrial Implant Development in a Murine Model of Endometriosis via openalex
- Effects of the Novel Orally Active Antiestrogen TZE-5323 on Experimental Endometriosis via openalex
- Efficacy of melatonin in the treatment of endometriosis: A phase II, randomized, double-blind, placebo-controlled trial via openalex
- Emerging drugs in endometriosis via openalex
- Endometrial changes from short-term therapy with CDB-4124, a selective progesterone receptor modulator via openalex
- Endometriosis via openalex
- Endometriosis and angiogenesis. via openalex
- Endometriosis in the male. via openalex
- ESHRE guideline for the diagnosis and treatment of endometriosis via openalex
- Genetic or Enzymatic Disruption of Aromatase Inhibits the Growth of Ectopic Uterine Tissue via openalex
- Hormone therapy for endometriosis and surgical menopause via openalex
- Identification and Quantification of Dopamine Receptor 2 in Human Eutopic and Ectopic Endometrium: A Novel Molecular Target for Endometriosis Therapy1 via openalex
- Immunohistochemical analysis of the role of angiogenic status in the vasculature of peritoneal endometriosis via openalex
- Inflammatory Status Influences Aromatase and Steroid Receptor Expression in Endometriosis via openalex
- Intrauterine administration of CDB-2914 (Ulipristal) suppresses the endometrium of rhesus macaques via openalex
- Involvement of estrogen receptor-related receptors in human ovarian endometriosis via openalex
- Lipoxin <scp>A</scp>4 Inhibits the Development of Endometriosis in Mice: The Role of Anti‐Inflammation and Anti‐Angiogenesis via openalex
- Medical treatment of endometriosis. via openalex
- Monocyte chemotactic protein-1 concentration in peritoneal fluid of women with endometriosis and its modulation of expression in mesothelial cells via openalex
- New medical treatments for endometriosis via openalex
- New trends for the medical treatment of endometriosis via openalex
- Novel Therapies Targeting Endometriosis via openalex
- Oral eicosapentaenoic acid supplementation as possible therapy for endometriosis via openalex
- Ovulation suppression for endometriosis via openalex
- Pentoxifylline for endometriosis via openalex
- Prediction of endometriosis with serum and peritoneal fluid markers: a prospective controlled trial via openalex
- Prostaglandin E2 Via Steroidogenic Factor-1 Coordinately Regulates Transcription of Steroidogenic Genes Necessary for Estrogen Synthesis in Endometriosis via openalex
- Regression of endometrial explants in a rat model of endometriosis treated with melatonin via openalex
- Return of Chronic Pelvic Pain From Endometriosis After Raloxifene Treatment via openalex
- Selective Estrogen-Receptor Modulators and Aromatase Inhibitors: Promising New Medical Therapies for Endometriosis? via openalex
- Simvastatin Protects against the Development of Endometriosis in a Nude Mouse Model via openalex
- Successful treatment of an aggressive recurrent post-menopausal endometriosis with an aromatase inhibitor via openalex
- Successful treatment of refractory endometriosis-related chronic pelvic pain with aromatase inhibitors in premenopausal patients via openalex
- Successful treatment of severe endometriosis in two premenopausal women with an aromatase inhibitor via openalex
- Suppression of Gonadotropins and Estradiol in Premenopausal Women by Oral Administration of the Nonpeptide Gonadotropin-Releasing Hormone Antagonist Elagolix via openalex
- The effects of letrozole and melatonin on surgically induced endometriosis in a rat model: a preliminary study via openalex
- The effects of metformin and letrozole on endometriosis and comparison of the two treatment agents in a rat model via openalex
- The effects of post-surgical administration of goserelin plus anastrozole compared to goserelin alone in patients with severe endometriosis: a prospective randomized trial via openalex
- The emerging use of aromatase inhibitors for endometriosis treatment via openalex
- The Epidemiology of Endometriosis via openalex
- The inhibitory effect of celecoxib and rosiglitazone on experimental endometriosis via openalex
- Treatment of Severe Postmenopausal Endometriosis With an Aromatase Inhibitor via openalex
- Treatment of severe recurrent endometriosis with an aromatase inhibitor in a young ovariectomised woman via openalex
- Treatment with Bazedoxifene, a Selective Estrogen Receptor Modulator, Causes Regression of Endometriosis in a Mouse Model via openalex
- Vascular density and distribution of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 (Flk-1) are significantly higher in patients with deeply infiltrating endometriosis affecting the rectum via openalex
- W1993692236 via openalex
- W2003598961 via openalex
- W2066119115 via openalex
- W2066250307 via openalex
- W2066865081 via openalex
- W2067201007 via openalex
- W2070878775 via openalex
- W2078741915 via openalex
- W2079224311 via openalex
- W2082368668 via openalex
- W2084506573 via openalex
- W2085759082 via openalex
- W2089803739 via openalex
- W2096980318 via openalex
- W2099423538 via openalex
- W2015065898 via openalex
- W1985959551 via openalex
- W2126728673 via openalex
- W1969169755 via openalex
- W2132577372 via openalex
- W1965172511 via openalex
- W2139304464 via openalex
- W2140246703 via openalex
- W2145213731 via openalex
- W2154377312 via openalex
- W2156928884 via openalex
- W2159803441 via openalex
- W2160433381 via openalex
- W2170519509 via openalex
- W2587790761 via openalex
- W4211081176 via openalex
- W69917799 via openalex
Cited by (7)
- The Role of Dietary Supplements in the Management of Endometriosis-Related Symptoms: Current Evidence Based on a Systematic Review of Randomized Controlled Trials 2026
- Baicalein Relieves Ferroptosis-Mediated Phagocytosis Inhibition of Macrophages in Ovarian Endometriosis 2022
- Discerning Endometriosis as a Multifaceted Entity: A Comprehensive Review 2020
- Increasing Trends in Deep Infiltrating Endometriosis (DIE) with Bilateral Endometrioma from Adolescence till Menopause 2020
- Endometriosis with infertility: A comprehensive review on the role of immune deregulation and immunomodulation therapy 2020
- Increasing trends in Deep Infiltrating Endometriosis (DIE) with Bilateral Endometrioma from Adolescence till Menopause: Case Series 2019
- Roles of cell migration and invasion mediated by Twist in endometriosis 2019
Source provenance
- europepmc
- last seen: 2026-09-05T06:14:40.014199+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:17:39.907309+00:00